• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vγ9Vδ2 T细胞对氨基双膦酸盐致敏的MCF-7乳腺肿瘤细胞的溶解作用。

Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.

作者信息

Dhar Swati, Chiplunkar Shubhada V

机构信息

Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.

出版信息

Cancer Immun. 2010 Nov 12;10:10.

PMID:21069948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2999943/
Abstract

Aminobisphosphonates are drugs administered for the treatment of bone resorption. They can indirectly activate peripheral γδ T cells and render tumor cells susceptible to lysis by Vγ9Vδ2 T cells. We have investigated the molecules involved in conjugate formation and killing of aminobisphosphonate-treated MCF-7 breast tumor cells by Vγ9Vδ2 T cells. Lysis of aminobisphosphonate (Pamidronate and Zoledronate)-treated MCF-7 tumor cells by Vγ9Vδ2 T cells was assessed by chromium release assays and time-lapse video microscopy. MCF-7 breast cancer cells were chosen as aminobisphosphonates are employed to alleviate bone resorption in this malignancy. Cell cycle profile and expression of MICA, ICAM-I and FasL on aminobisphosphonate-sensitized MCF-7 breast tumor cells was confirmed by flow cytometry. Involvement of γδ TCR and NKG2D in mediating cytotoxicity of aminobisphosphonate-treated MCF-7 breast tumor cells by Vγ9Vδ2 T cells was assessed using blocking antibodies in chromium release assays. MCF-7 tumor cells pretreated with Pamidronate and Zoledronate were efficiently lysed by Vγ9Vδ2 T cells. Pamidronate and Zoledronate treatment of MCF-7 cells induced S phase arrest and did not alter expression of MICA, ICAM-I and FasL. Blocking γδ TCR and NKG2D on Vγ9Vδ2 T cells inhibited lysis of Pamidronate and Zoledronate-treated MCF-7 cells. Inhibiting the perforin-granzyme pathway in Vγ9Vδ2 T cells using concanamycin A reduced their ability to lyse aminobisphosphonate-treated MCF-7 cells. Vγ9Vδ2 T cells form strong conjugates with aminobisphosphonate-treated MCF-7 breast tumor cells. γδ TCR, NKG2D and perforin-granzyme pathway are involved in the lysis of MCF-7 breast tumor cells treated with aminobisphosphonates by Vγ9Vδ2 T cells.

摘要

氨基双膦酸盐是用于治疗骨吸收的药物。它们可间接激活外周γδT细胞,并使肿瘤细胞易于被Vγ9Vδ2T细胞裂解。我们研究了Vγ9Vδ2T细胞与经氨基双膦酸盐处理的MCF-7乳腺肿瘤细胞形成结合物并将其杀伤过程中涉及的分子。通过铬释放试验和延时视频显微镜评估Vγ9Vδ2T细胞对经氨基双膦酸盐(帕米膦酸盐和唑来膦酸盐)处理的MCF-7肿瘤细胞的裂解作用。选择MCF-7乳腺癌细胞是因为在这种恶性肿瘤中使用氨基双膦酸盐来减轻骨吸收。通过流式细胞术确认了经氨基双膦酸盐致敏的MCF-7乳腺肿瘤细胞的细胞周期分布以及MICA、ICAM-1和FasL的表达。在铬释放试验中使用阻断抗体评估γδTCR和NKG2D在介导Vγ9Vδ2T细胞对经氨基双膦酸盐处理的MCF-7乳腺肿瘤细胞的细胞毒性中的作用。用帕米膦酸盐和唑来膦酸盐预处理的MCF-7肿瘤细胞被Vγ9Vδ2T细胞有效裂解。帕米膦酸盐和唑来膦酸盐处理MCF-7细胞诱导S期停滞,且未改变MICA、ICAM-1和FasL的表达。阻断Vγ9Vδ2T细胞上的γδTCR和NKG2D可抑制对经帕米膦酸盐和唑来膦酸盐处理的MCF-7细胞的裂解。使用 concanamycin A抑制Vγ9Vδ2T细胞中的穿孔素-颗粒酶途径会降低它们裂解经氨基双膦酸盐处理的MCF-7细胞的能力。Vγ9Vδ2T细胞与经氨基双膦酸盐处理的MCF-7乳腺肿瘤细胞形成强结合物。γδTCR、NKG2D和穿孔素-颗粒酶途径参与Vγ9Vδ2T细胞对经氨基双膦酸盐处理的MCF-7乳腺肿瘤细胞的裂解。

相似文献

1
Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.Vγ9Vδ2 T细胞对氨基双膦酸盐致敏的MCF-7乳腺肿瘤细胞的溶解作用。
Cancer Immun. 2010 Nov 12;10:10.
2
Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.经氨基双膦酸盐预处理的树突状细胞触发成功的 Vγ9Vδ2 T 细胞扩增,用于晚期癌症患者的免疫治疗。
Cancer Immunol Immunother. 2010 Nov;59(11):1611-9. doi: 10.1007/s00262-010-0887-0. Epub 2010 Jun 26.
3
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.化疗和唑来膦酸使实体瘤细胞对Vγ9Vδ2 T细胞的细胞毒性敏感。
Cancer Immunol Immunother. 2007 Aug;56(8):1285-97. doi: 10.1007/s00262-007-0279-2. Epub 2007 Jan 31.
4
Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.在溶骨性乳腺癌小鼠模型中,体外扩增的Vγ9Vδ2 T细胞与唑来膦酸联合进行过继性转移可抑制肿瘤生长并限制骨溶解。
Cancer Lett. 2017 Feb 1;386:141-150. doi: 10.1016/j.canlet.2016.11.013. Epub 2016 Nov 16.
5
Expansion of human peripheral blood γδ T cells using zoledronate.使用唑来膦酸扩增人外周血γδ T细胞。
J Vis Exp. 2011 Sep 9(55):3182. doi: 10.3791/3182.
6
Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells.曲妥珠单抗增强了Vγ9Vδ2 T细胞对唑来膦酸致敏的骨肉瘤细胞的细胞毒性。
Int Immunopharmacol. 2015 Sep;28(1):160-7. doi: 10.1016/j.intimp.2015.06.002. Epub 2015 Jun 10.
7
Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.唑来膦酸有助于从癌症患者体内大规模离体扩增功能性γδ T细胞,用于过继性免疫治疗。
Cytotherapy. 2008;10(8):842-56. doi: 10.1080/14653240802419328.
8
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.唑来膦酸和低剂量白细胞介素-2体内调节 Vgamma9Vdelta2 T 细胞用于晚期乳腺癌患者的免疫治疗。
Clin Exp Immunol. 2010 Aug;161(2):290-7. doi: 10.1111/j.1365-2249.2010.04167.x. Epub 2010 May 10.
9
Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.Vγ9Vδ2 T细胞介导的对人类实体瘤的识别。肝细胞癌和结直肠癌免疫治疗的潜力。
Cancer Immunol Immunother. 2008 Apr;57(4):531-9. doi: 10.1007/s00262-007-0391-3. Epub 2007 Sep 1.
10
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.γδ T 细胞自体免疫疗法治疗转移性实体瘤的临床评估。
Br J Cancer. 2011 Sep 6;105(6):778-86. doi: 10.1038/bjc.2011.293. Epub 2011 Aug 16.

引用本文的文献

1
The Cytotoxic Potential of Humanized γδ T Cells Against Human Cancer Cell Lines in .人源化γδ T细胞对人癌细胞系的细胞毒性潜力
Cells. 2025 Aug 4;14(15):1197. doi: 10.3390/cells14151197.
2
γδ T Cells: Game Changers in Immune Cell Therapy for Cancer.γδ T细胞:癌症免疫细胞治疗中的变革者。
Cancers (Basel). 2025 Mar 21;17(7):1063. doi: 10.3390/cancers17071063.
3
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives.免疫细胞在肿瘤微环境中与癌细胞直接相互作用:一枚硬币的两面及其未来展望。
Front Immunol. 2024 May 22;15:1388176. doi: 10.3389/fimmu.2024.1388176. eCollection 2024.
4
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential.用于乳腺癌的工程化过继性T细胞疗法:当前进展、挑战与潜力
Cancers (Basel). 2023 Dec 26;16(1):124. doi: 10.3390/cancers16010124.
5
Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid.卡介苗(BCG)通过 Vδ2+T 细胞诱导比氨基双膦酸盐药物唑来膦酸更优的抗肿瘤反应。
Clin Exp Immunol. 2022 Jun 23;208(3):301-315. doi: 10.1093/cei/uxac032.
6
Transcriptome Signature of Vγ9Vδ2 T Cells Treated With Phosphoantigens and Notch Inhibitor Reveals Interplay Between TCR and Notch Signaling Pathways.磷酸抗原和 Notch 抑制剂处理的 Vγ9Vδ2 T 细胞的转录组特征揭示了 TCR 和 Notch 信号通路之间的相互作用。
Front Immunol. 2021 Aug 30;12:660361. doi: 10.3389/fimmu.2021.660361. eCollection 2021.
7
Biologically Active α-Amino Amide Analogs and γδ T Cells-A Unique Anticancer Approach for Leukemia.具有生物活性的α-氨基酰胺类似物与γδ T细胞——一种独特的白血病抗癌方法
Front Oncol. 2021 Jul 12;11:706586. doi: 10.3389/fonc.2021.706586. eCollection 2021.
8
The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.人类 γδ T 细胞的双重作用:抗肿瘤或促进肿瘤。
Front Immunol. 2021 Feb 16;11:619954. doi: 10.3389/fimmu.2020.619954. eCollection 2020.
9
TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of γδ T cells.TIM-3 阻断联合双特异性抗体 MT110 增强 γδ T 细胞的抗肿瘤作用。
Cancer Immunol Immunother. 2020 Dec;69(12):2571-2587. doi: 10.1007/s00262-020-02638-0. Epub 2020 Jun 25.
10
Targeting the interleukin-17 immune axis for cancer immunotherapy.针对白细胞介素-17 免疫轴的癌症免疫疗法。
J Exp Med. 2020 Jan 6;217(1). doi: 10.1084/jem.20190456.

本文引用的文献

1
Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells.唑来膦酸可导致胆管癌细胞停滞于S期,但无法诱导其凋亡。
Biochem Pharmacol. 2009 Jul 15;78(2):133-41. doi: 10.1016/j.bcp.2009.04.004. Epub 2009 Apr 11.
2
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.γδ T淋巴细胞对人结肠癌干细胞的高效杀伤作用。
J Immunol. 2009 Jun 1;182(11):7287-96. doi: 10.4049/jimmunol.0804288.
3
Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.唑来膦酸激活的Vγ9γδ T细胞免疫疗法用于多发性骨髓瘤患者的临床和免疫学评估
Exp Hematol. 2009 Aug;37(8):956-68. doi: 10.1016/j.exphem.2009.04.008. Epub 2009 May 4.
4
DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.DNAX辅助分子-1(CD226)促进Vγ9Vδ2 T细胞对人肝癌细胞的裂解作用。
Eur J Immunol. 2009 May;39(5):1361-8. doi: 10.1002/eji.200838409.
5
Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.唑来膦酸在体内破骨细胞和体外MCF-7细胞中诱导促凋亡ATP类似物和异戊烯基焦磷酸的形成。
Br J Pharmacol. 2009 Jun;157(3):427-35. doi: 10.1111/j.1476-5381.2009.00160.x. Epub 2009 Apr 3.
6
Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.异戊烯基焦磷酸激活的CD56+γδ T淋巴细胞对人鳞状细胞癌显示出强大的抗肿瘤活性。
Clin Cancer Res. 2008 Jul 1;14(13):4232-40. doi: 10.1158/1078-0432.CCR-07-4912.
7
The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy.γδ T细胞的可塑性:固有免疫、抗原呈递与新型免疫疗法。
Cell Mol Immunol. 2008 Jun;5(3):161-70. doi: 10.1038/cmi.2008.20.
8
The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis.双膦酸盐唑来膦酸可抑制HCT-116结肠癌细胞的生长并诱导肿瘤细胞凋亡。
Apoptosis. 2008 Jun;13(6):782-9. doi: 10.1007/s10495-008-0211-z.
9
Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7.异戊二烯非依赖途径参与了双膦酸盐类药物利塞膦酸钠诱导的细胞凋亡,其中Bim在乳腺癌细胞系MCF-7中发挥关键作用。
Oncol Rep. 2007 Nov;18(5):1291-8.
10
Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.唑来膦酸不能诱导细胞凋亡,但可减缓非小细胞肺癌的肿瘤生长并延长生存期。
Lung Cancer. 2008 Feb;59(2):180-91. doi: 10.1016/j.lungcan.2007.08.026. Epub 2007 Sep 27.